BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada
Clinical trial NCT00272779 · COMPLETED
Trial details
- NCT number
- NCT00272779
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2007-06-01
- Enrollment
- 1057
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.